Cargando…
Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities
BACKGROUND: Healthcare workers are at increased risk of infection due to occupational exposure to SARS-CoV-2-infected patients. The objective of this study was to determine the seroprevalence of SARS-CoV-2 in healthcare workers in Colombia. METHODS: This study is a cross-sectional study focused on e...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577941/ https://www.ncbi.nlm.nih.gov/pubmed/34740981 http://dx.doi.org/10.1136/oemed-2021-107487 |
_version_ | 1784596167672201216 |
---|---|
author | Malagón-Rojas, Jeadran Nevardo Mercado-Reyes, Marcela Toloza-Pérez, Yezith G Parra Barrera, Eliana L Palma, Marien Muñoz, Esperanza López, Ronald Almentero, Julia Rubio, Vivian V Ibáñez, Edgar Téllez, Eliana Delgado-Murcia, Lucy G Jimenez, Claudia P Viasus-Pérez, Diego Galindo, Marisol Lagos, Luisa |
author_facet | Malagón-Rojas, Jeadran Nevardo Mercado-Reyes, Marcela Toloza-Pérez, Yezith G Parra Barrera, Eliana L Palma, Marien Muñoz, Esperanza López, Ronald Almentero, Julia Rubio, Vivian V Ibáñez, Edgar Téllez, Eliana Delgado-Murcia, Lucy G Jimenez, Claudia P Viasus-Pérez, Diego Galindo, Marisol Lagos, Luisa |
author_sort | Malagón-Rojas, Jeadran Nevardo |
collection | PubMed |
description | BACKGROUND: Healthcare workers are at increased risk of infection due to occupational exposure to SARS-CoV-2-infected patients. The objective of this study was to determine the seroprevalence of SARS-CoV-2 in healthcare workers in Colombia. METHODS: This study is a cross-sectional study focused on estimating the seroprevalence of SARS-CoV-2 antibodies in healthcare workers from 65 hospitals in 10 cities in Colombia during the second semester of 2020. The seroprevalence was determined using an automated immunoassay (Abbott SARS-CoV-2 CLIA IgG). The study included a survey to establish the sociodemographic variables and the risk of infection. A multivariate model was used to evaluate the association between the results of seroprevalence and risk factors. RESULTS: The global seroprevalence of antibodies against SARS-CoV-2 was 35% (95% Bayesian CI 33% to 37%). All the personnel reported the use of protective equipment. General services personnel and nurses presented the highest ratios of seroprevalence among the healthcare workers. Low socioeconomic strata have shown a strong association with seropositivity. CONCLUSION: This study estimates the prevalence of SARS-CoV-2 infection among healthcare workers. Even though all the personnel reported the use of protective equipment, the seroprevalence in the general services personnel and nurses was high. Also, a significant difference by cities was observed. |
format | Online Article Text |
id | pubmed-8577941 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-85779412021-11-10 Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities Malagón-Rojas, Jeadran Nevardo Mercado-Reyes, Marcela Toloza-Pérez, Yezith G Parra Barrera, Eliana L Palma, Marien Muñoz, Esperanza López, Ronald Almentero, Julia Rubio, Vivian V Ibáñez, Edgar Téllez, Eliana Delgado-Murcia, Lucy G Jimenez, Claudia P Viasus-Pérez, Diego Galindo, Marisol Lagos, Luisa Occup Environ Med Workplace BACKGROUND: Healthcare workers are at increased risk of infection due to occupational exposure to SARS-CoV-2-infected patients. The objective of this study was to determine the seroprevalence of SARS-CoV-2 in healthcare workers in Colombia. METHODS: This study is a cross-sectional study focused on estimating the seroprevalence of SARS-CoV-2 antibodies in healthcare workers from 65 hospitals in 10 cities in Colombia during the second semester of 2020. The seroprevalence was determined using an automated immunoassay (Abbott SARS-CoV-2 CLIA IgG). The study included a survey to establish the sociodemographic variables and the risk of infection. A multivariate model was used to evaluate the association between the results of seroprevalence and risk factors. RESULTS: The global seroprevalence of antibodies against SARS-CoV-2 was 35% (95% Bayesian CI 33% to 37%). All the personnel reported the use of protective equipment. General services personnel and nurses presented the highest ratios of seroprevalence among the healthcare workers. Low socioeconomic strata have shown a strong association with seropositivity. CONCLUSION: This study estimates the prevalence of SARS-CoV-2 infection among healthcare workers. Even though all the personnel reported the use of protective equipment, the seroprevalence in the general services personnel and nurses was high. Also, a significant difference by cities was observed. BMJ Publishing Group 2022-06 2021-11-05 /pmc/articles/PMC8577941/ /pubmed/34740981 http://dx.doi.org/10.1136/oemed-2021-107487 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Workplace Malagón-Rojas, Jeadran Nevardo Mercado-Reyes, Marcela Toloza-Pérez, Yezith G Parra Barrera, Eliana L Palma, Marien Muñoz, Esperanza López, Ronald Almentero, Julia Rubio, Vivian V Ibáñez, Edgar Téllez, Eliana Delgado-Murcia, Lucy G Jimenez, Claudia P Viasus-Pérez, Diego Galindo, Marisol Lagos, Luisa Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities |
title | Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities |
title_full | Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities |
title_fullStr | Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities |
title_full_unstemmed | Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities |
title_short | Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities |
title_sort | seroprevalence of the sars-cov-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 colombian cities |
topic | Workplace |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577941/ https://www.ncbi.nlm.nih.gov/pubmed/34740981 http://dx.doi.org/10.1136/oemed-2021-107487 |
work_keys_str_mv | AT malagonrojasjeadrannevardo seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities AT mercadoreyesmarcela seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities AT tolozaperezyezithg seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities AT parrabarreraelianal seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities AT palmamarien seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities AT munozesperanza seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities AT lopezronald seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities AT almenterojulia seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities AT rubiovivianv seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities AT ibanezedgar seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities AT tellezeliana seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities AT delgadomurcialucyg seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities AT jimenezclaudiap seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities AT viasusperezdiego seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities AT galindomarisol seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities AT lagosluisa seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities AT seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities |